In the last trading session, 1.05 million Caredx Inc (NASDAQ:CDNA) shares changed hands as the company’s beta touched 1.96. With the company’s per share price at $20.89 changed hands at -$0.48 or -2.25% during last session, the market valuation stood at $1.12B. CDNA’s last price was a discount, traded about -66.78% off its 52-week high of $34.84. The share price had its 52-week low at $7.42, which suggests the last value was 64.48% up since then.
Analysts gave the Caredx Inc (CDNA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.89. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CDNA as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Caredx Inc’s EPS for the current quarter is expected to be 0.15.
Caredx Inc (NASDAQ:CDNA) trade information
Instantly CDNA was in red as seen at the end of in last trading. With action -14.70%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -2.43%, with the 5-day performance at -14.70% in the red. However, in the 30-day time frame, Caredx Inc (NASDAQ:CDNA) is -6.49% down.
The consensus price target for the stock as assigned by Wall Street analysts is 35, meaning bulls need an upside of 40.31% from its current market value. According to analyst projections, CDNA’s forecast low is 35 with 35 as the target high. To hit the forecast high, the stock’s price needs a -67.54% plunge from its current level, while the stock would need to soar -67.54% for it to hit the projected low.
Caredx Inc (CDNA) estimates and forecasts
Year-over-year growth is forecast to reach 18.52% up from the last financial year.
Consensus estimates given by 6 financial analysts project the company’s revenue in the current quarter to hit an average of 84.56M. 6 analysts are of the opinion that Caredx Inc’s revenue for the current quarter will be 85.31M. The company’s revenue for the corresponding quarters a year ago was 65.57M and 72.05M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 28.96%. The estimates for the next quarter sales put growth at 18.40%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -21.96%. The 2025 estimates are for Caredx Inc earnings to increase by 74.72%, but the outlook for the next 5-year period is at 73.75% per year.
CDNA Dividends
Caredx Inc is expected to release its next quarterly earnings report in March.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 10.1283% or 5.29 million shares worth $82.1 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were ARK ETF Tr-ARK Genomic Revolution ETF and Vanguard Total Stock Market Index Fund . With 2.38 shares estimated at $49.63 million under it, the former controlled 4.43% of total outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held about 2.83% of the shares, roughly 1.52 shares worth around $31.7 million.
